{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T05:10:52Z","timestamp":1778217052511,"version":"3.51.4"},"reference-count":13,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>We report a case of suspected donor-transmitted squamous cell carcinoma (SCC) in a kidney transplant recipient who received an organ from a deceased donor with no evidence of malignancy at the time of procurement. Approximately one year after transplantation, the recipient developed metastatic SCC with bone and lung involvement. Molecular genotyping was inconclusive regarding donor origin, as tumor cells lacked human leukocyte antigen (HLA) expression. Notably, a second recipient who received the liver from the same donor also developed SCC and subsequently died, raising suspicion of donor transmission. Allograft nephrectomy and complete withdrawal of immunosuppression were initially considered; however, the patient declined due to concerns regarding quality of life associated with dialysis. Systemic chemotherapy was initiated but resulted in disease progression after two months. Treatment was subsequently switched to the checkpoint inhibitor cemiplimab, with concurrent discontinuation of all immunosuppressive therapy except prednisone. Acute graft rejection occurred after two cycles, and the patient resumed dialysis. Subsequent imaging demonstrated findings consistent with pseudoprogression before achieving near-complete remission. The patient completed two years of immunotherapy, after which treatment was discontinued, and remains under surveillance with ongoing near-complete remission. This case highlights the potential role of checkpoint inhibition combined with immunosuppression withdrawal as a therapeutic strategy in in selected patients with donor-transmitted SCC following kidney transplantation.<\/jats:p>","DOI":"10.3389\/fonc.2026.1770929","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T04:42:46Z","timestamp":1778215366000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Donor-transmitted squamous cell carcinoma in kidney transplant recipient successfully treated with checkpoint inhibitors: a case report"],"prefix":"10.3389","volume":"16","author":[{"given":"Georgios","family":"Fountoukidis","sequence":"first","affiliation":[{"name":"Department of Oncology, Faculty of Medicine and Health, \u00d6rebro University","place":["\u00d6rebro, Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr","family":"Jakuszewski","sequence":"additional","affiliation":[{"name":"Department of Renal Medicine, Faculty of Medicine and Health, \u00d6rebro University","place":["\u00d6rebro, Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frida","family":"Jakobsson","sequence":"additional","affiliation":[{"name":"Department of Oncology, Faculty of Medicine and Health, \u00d6rebro University","place":["\u00d6rebro, Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonis","family":"Valachis","sequence":"additional","affiliation":[{"name":"Department of Oncology, Faculty of Medicine and Health, \u00d6rebro University","place":["\u00d6rebro, Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200211270-00012","article-title":"Risk for tumor and other disease transmission by transplantation: a population-based study of unrecognized Malignancies and other diseases in organ donors","volume":"74","author":"Birkeland","year":"2002","journal-title":"Transplantation"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2011.03493.x","article-title":"An update on donor-derived disease transmission in organ transplantation","volume":"11","author":"Ison","year":"2011","journal-title":"Am J Transplant"},{"key":"B3","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1111\/ajt.16178","article-title":"Ten years of donor-derived disease: a report of the disease transmission advisory committee","volume":"21","author":"Kaul","year":"2021","journal-title":"Am J Transplant"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s40620-020-00775-4","article-title":"Donor-transmitted cancer in kidney transplant recipients: a systematic review","volume":"33","author":"Eccher","year":"2020","journal-title":"J Nephrol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2019-0659","article-title":"The safety and efficacy of checkpoint inhibitors in transplant recipients: a case series and systematic review of literature","volume":"25","author":"Kumar","year":"2020","journal-title":"Oncologist"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2017.06.007","article-title":"Donor-derived metastatic melanoma and checkpoint inhibition","volume":"49","author":"Boyle","year":"2017","journal-title":"Transplant Proc."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1097\/TXD.0000000000001090","article-title":"Metastatic donor-derived Malignancies following simultaneous pancreas-kidney transplant: three case reports and management strategies","volume":"7","author":"Amara","year":"2020","journal-title":"Transplant Direct"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.trim.2024.102117","article-title":"Long-term survival of kidney-transplant recipient with donor-transmitted Malignant melanoma after provoked rejection","volume":"87","author":"Kommer","year":"2024","journal-title":"Transpl Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.4658","article-title":"Successful treatment and five years of disease-free survival in a donor transmitted metastatic melanoma with ipilimumab therapy","volume":"11","author":"Singh","year":"2019","journal-title":"Cureus"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s10561-007-9036-1","article-title":"Donor-derived Malignancy following transplantation: a review","volume":"8","author":"Gandhi","year":"2007","journal-title":"Cell Tissue Banking"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2020.7622","article-title":"Molecular insights in transmission of cancer from an organ donor to four transplant recipients","volume":"18","author":"Atreya","year":"2020","journal-title":"J Natl Compr Canc Netw"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.01498","article-title":"Cemiplimab for kidney transplant recipients with advanced cutaneous squamous cell carcinoma","volume":"42","author":"Hanna","year":"2024","journal-title":"JCO"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.01497","article-title":"Nivolumab + Tacrolimus + Prednisone \u00b1 Ipilimumab for kidney transplant recipients with advanced cutaneous cancers","volume":"42","author":"Schenk","year":"2024","journal-title":"J Clin Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1770929\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T04:42:57Z","timestamp":1778215377000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1770929\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,8]]},"references-count":13,"alternative-id":["10.3389\/fonc.2026.1770929"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1770929","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,8]]},"article-number":"1770929"}}